Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS). Several therapies for it exist, although there is no known cure. The...
Industry-leading Multiple Sclerosis Portfolio
Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying disease. Many treatments...
Alzheimer’s Disease and Dementia · Amyotrophic Lateral Sclerosis (ALS) · Friedreich Ataxia · Lupus · Multiple Sclerosis (MS) · Postpartum Depression · Spinal Muscular Atrophy (SMA)
Biogen Cookies Cookies ... Biogen Cookies Cookies Information for Get in touch Explore We recommend © 2024 Biogen Terms & Conditions Privacy Center Notice to CA Residents Consumer Health Data Privacy Policy Cookie...
As generic competition bites for multiple sclerosis drug Tecfidera, Biogen is reportedly making some cost-savings efforts.
Making an Impact with Analytics: Khalid’s Career Journey · People & Culture ; The Evolving Field of MS Research · Multiple Sclerosis ; From PharmD Student to Biogen Fellow · People & Culture
Alzheimer’s Disease and Dementia ; Amyotrophic Lateral Sclerosis (ALS) ; Friedreich Ataxia ; Lupus ; Multiple Sclerosis (MS) ; Postpartum Depression ; Spinal Muscular Atrophy (SMA)
R&D Expertise Our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines. ; Medicines Our medicines aim to improve the well-being of people around the world. ; Manufacturing Our technology and engineering capabilities help bring our high-quality medicines to market.
Because Biogen's multiple sclerosis drugs cost between $50,000 and $80,000 per year, copays can be thousands of dollars per patient, Humana says. Those copays are a “tiny fraction” of...